Why the study?
Does fluid loading with 500 mL hydroxyethyl starch alter left ventricular end-diastolic volume and stroke volume variability differently in patients with ESRD compared to non-ESRD controls?
Does fluid loading with 500 mL hydroxyethyl starch alter left ventricular end-diastolic volume and stroke volume variability differently in patients with ESRD compared to non-ESRD controls?
In patients with end-stage renal disease, stroke volume variability is a more reliable indicator of fluid responsiveness than left ventricular end-diastolic volume.
SVV may better indicate fluid responsiveness than LVEDV in ESRD; hypothesis-generating and should not yet change practice.
PURPOSE: The aim of this study was to investigate fluid loading-induced changes in left ventricular end-diastolic volume (LVEDV) and stroke volume variability (SVV) in patients with end-stage renal disease (ESRD) using real-time three-dimensional transesophageal echocardiography and the Vigileo-FloTrac system. PATIENTS AND METHODS: After obtaining ethics committee approval and informed consent, 28 patients undergoing peripheral vascular procedures were studied. Fourteen patients with ESRD on hemodialysis (HD) were assigned to the HD group and 14 patients without ESRD were assigned to the control group. Institutional standardized general anesthesia was provided in both groups. SVV was measured using the Vigileo-FloTrac system. Simultaneously, a full-volume three-dimensional transesophageal echocardiography dataset was acquired to measure LVEDV, left ventricular end-systolic volume, and left ventricular ejection fraction. Measurements were obtained before and after loading 500 mL hydroxyethyl starch over 30 minutes in both groups. RESULTS: In the control group, intravenous colloid infusion was associated with a significant decrease in SVV (13.8%±2.6% to 6.5%±2.6%, P<0.001) and a significant increase in LVEDV (83.6±23.4 mL to 96.1±28.8 mL, P<0.001). While SVV significantly decreased after infusion in the HD group (16.2%±6.0% to 6.2%±2.8%, P<0.001), there was no significant change in LVEDV. CONCLUSION: Our preliminary data suggest that fluid responsiveness can be assessed not by LVEDV but also by SVV due to underlying cardiovascular pathophysiology in patients with ESRD.
No takes yet. Share an insight, caveat, or question.
Kanda et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: